L Pavliv - US Patent 8,148,356, 2012 - Google Patents
This invention relates to novel acetylcysteine compositions in solution, comprising acetylcysteine and Which are substan tially free of metal chelating agents, such as EDTA …
GR Painter, MR Almond - US Patent 8,614,200, 2013 - Google Patents
The present invention provides methods of treating viral infection of the eye or posterior ocular condition including administering a pharmaceutical composition comprising a …
M Almond, B Lampert, ER Lanier, RW Ware - US Patent 9,006,218, 2015 - Google Patents
1944, 530 A 1/1934 Schonburg 3.422, 021 A 1/1969 Roy 3,468,935 A 9, 1969 Peck 4,327,039 A 4, 1982 Blum et al. 4,444,766 A 4, 1984 Bosies et al. 4,562,179 A 12/1985 …
L Pavliv - US Patent 8,399,445, 2013 - Google Patents
This invention relates to novel acetylcysteine compositions in solution, comprising acetylcysteine and which are substantially free of metal chelating agents, such as EDTA …
ER Lanier, MR Almond, GR Painter - US Patent 8,993,542, 2015 - Google Patents
The present invention provides methods of treating human immunodeficiency virus (HIV) and/or hepatitis B virus (HBV) infection, including administering a compound described in …
L Pavliv - US Patent 8,653,061, 2014 - Google Patents
This invention relates to novel acetylcysteine compositions in solution, comprising acetylcysteine and which are substantially free of metal chelating agents, such as EDTA …
R Friedman - US Patent App. 11/794,058, 2008 - Google Patents
(57) ABSTRACT A method for the treatment of pain and/or inflammation in a subject by the administration of N-acetyl-cysteine (NAC) or derivative thereof and a pain and/or anti …
L Pavliv - US Patent 8,952,065, 2015 - Google Patents
Related US Application Data (62) Division of application No. 13/757,721, filed on Feb. 1, 2013, now Pat. No. 8,653,061, which is a division of application No. 13/406,175, filed on …
MR Almond, GR Painter - US Patent App. 12/888,175, 2011 - Google Patents
The present application provides methods and compositions for improving the bioavailability of a lipid-containing antivi ral compound, and in particular, an antiviral lipid-containing …